July 2024 – Page 8 – Goldea Capital

Thumzup® Welcomes Hi Five Energy Drink to its Proprietary Cash Rewards Platform

Written by Customer Service on July 31, 2024. Posted in Public Companies.

Thumzup Media Corporation Thumzup® Welcomes Hi Five Energy Drink to its Proprietary Cash Rewards Platform Order Hi Five Energy Drink today and earn cash for sharing your experience through the Thumzup app Los Angeles, CA, July 31, 2024 (GLOBE NEWSWIRE) — Thumzup Media Corporation (“Thumzup” or the “Company”) (OTCQB: TZUP), an innovator in social media branding and marketing solutions, is excited to welcome Hi Five Energy Drink (“Hi Five”) to its growing roster of advertising partners on the Company’s proprietary social media AdTech platform. Hi Five believes that energy drinks should be more than just a quick pick-me-up. The company has made it their mission to create energy drinks with high-quality ingredients, sourcing only the finest to create a product that not only boosts energy but also supports...

RENI – Resilient Energy Starts Process For 2nd Defense Drone Industry Acquisition

Written by Customer Service on July 31, 2024. Posted in Public Companies.

Houston, July 31, 2024 (GLOBE NEWSWIRE) — RENI – Resilient Energy Starts Process For 2nd Defense Drone Industry Acquisition HOUSTON, July 29, 2024/ — Resilient Energy, Inc. (OTC Markets: RENI) (“RENI” or “the Company”) releases a market update announcing it has entered in discussions for a second Defense & Drone acquisition.The negotiations are anticipated to conclude in the coming weeks. The Company will issue a formal statement and the necessary regulatory filings.The target’s business is growing monthly and offers a unique product to a variety of industries and end customers including commercial, government and defense companies. RENI’s CEO, Mr. Jon Bianco, stated, “We are dedicated to finding opportunities in advanced technology areas. Our intention is to acquire revenue...

Palisade Bio Participates in Virtual Investor “What this Means” Segment

Written by Customer Service on July 31, 2024. Posted in Public Companies.

Mitch Jones, MD, PhD, CMO of Palisade Bio highlights recent findings from a microbiome study confirming local bioactivation of lead product candidate, PALI-2108 Carlsbad, CA, July 31, 2024 (GLOBE NEWSWIRE) — Palisade Bio, Inc. (Nasdaq: PALI) (the “Company”), a biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases, today announced the release of a Virtual Investor “What This Means” segment. As part of this “What this Means” segment, Mitchell Jones, MD, PhD, Chief Medical Officer of Palisade Bio discusses the successful completion of a microbiome study confirming bacterial enzymes for local bioactivation of lead product candidate, PALI-2108, and what this means for its planned Phase 1 human clinical study for the treatment of Ulcerative...

Rhythm Pharmaceuticals Announces European Commission Expands ▼IMCIVREE® (setmelanotide) Marketing Authorization to include Children as Young as 2 Years Old

Written by Customer Service on July 31, 2024. Posted in Public Companies.

IMCIVREE now authorized as treatment of obesity and control of hunger in adult patients and pediatric patients 2 years old or older with Bardet Biedl syndrome or POMC, PCSK1, or LEPR deficiency BOSTON, July 31, 2024 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families living with rare neuroendocrine diseases, today announced that the European Commission (EC) expanded the marketing authorization for IMCIVREE® (setmelanotide) to include children between 2 and younger than 6 years old with obesity due to Bardet Biedl syndrome (BBS) or pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1 (PCSK1), or leptin receptor (LEPR) deficiency. “Today marks what we believe to be an important milestone...

Euroseas Ltd. Sets Date for the Release of Second Quarter 2024 Results, Conference Call and Webcast

Written by Customer Service on July 31, 2024. Posted in Public Companies.

ATHENS, Greece, July 31, 2024 (GLOBE NEWSWIRE) — Euroseas Ltd. (NASDAQ: ESEA), an owner and operator of container carrier vessels and provider of seaborne transportation for containerized cargoes, announced today that it will release its financial results for the second quarter ended June 30, 2024, on August 6, 2024 before market opens in New York. Later on, the same day, Tuesday, August 6, 2024 at 10:00 a.m. Eastern Time, the Company’s management will host a conference call and webcast to discuss the results. Conference Call details:Participants should dial into the call 10 minutes before the scheduled time using the following numbers: 877 405 1226 (US Toll-Free Dial In) or +1 201 689 7823 (US and Standard International Dial In). Please quote “Euroseas” to the operator and/or conference ID 13748264. Click here for additional...

N2OFF, INC. Entered into an Agreement to Fund up to € 8 million for 50% Rights in Several Solar PV Projects to be Developed by Solterra Renewable Energy Ltd.

Written by Customer Service on July 31, 2024. Posted in Public Companies.

First PV project in a capacity of 111 MW, received a municipal approval as well as an indicative solution for grid connection by a large regional energy service provider in Germany Neve Yarak, Israel, July 31, 2024 (GLOBE NEWSWIRE) — N2OFF, Inc. (NASDAQ: NITO) (FSE:80W) (“N2OFF” and the “Company”), a clean tech company engaged in sustainable solutions for energy and innovation for the agri- tech, announced today that together with a number of private investors (the “Investors”), it entered into an agreement with Solterra Renewable Energy Ltd. (“Solterra”), to fund up to €8 million solar PV (photovoltaic) projects. The first project which was agreed upon is planned in Melz, Germany, with a total Capacity of 111 MWp (Megawatt peak) for which the Company and Investors will loan an aggregate amount of €2.08 million. Yair Harel, Solterra’s...

Celularity Reports Full Year 2023 Combined Net Sales of $22.8 Million, a 26.7% Increase Over Full Year 2022, and Announces First Half 2024 Expected Combined Net Sales of $26.9 Million Representing 290% Growth Over First Half 2023

Written by Customer Service on July 31, 2024. Posted in Earnings Releases And Operating Results.

For the first quarter 2024, Celularity expects combined net sales of $14.8 million for its advanced biomaterial product and biobanking businesses, compared to the $10.25 million to $11.5 million guidance range previously announced in February. Celularity’s expected combined net sales for the first half 2024 are $25.8 to $27.8 million compared to $6.9 million of net sales in the first of 2023 at the midpoint of the 2024 range. Celularity reiterated it is on track to file a 510(k) premarket submission for its Celularity Tendon Wrap in the second half 2025, the first of three planned advanced biomaterial medical devices. FLORHAM PARK, N.J., July 31, 2024 (GLOBE NEWSWIRE) — Celularity Inc. (Nasdaq: CELU) (“Celularity”) a regenerative and cellular medicine company developing placental-derived allogeneic cell therapies and advanced...

Rail Vision Successfully Installed its AI- based Product at a Leading Global Mining Company

Written by Customer Service on July 31, 2024. Posted in Public Companies.

The mining Company is one of the world’s largest producers of metals Ra’anana, Israel, July 31, 2024 (GLOBE NEWSWIRE) — Rail Vision Ltd. (Nasdaq: RVSN) (the “Company”), a technology company at the forefront of revolutionizing railway safety and the data-related market, announced today it has successfully installed its product at one of Latin America’s leading mining companies. Following a successful delivery, Rail Vision’s team arrived at the mining company’s installation site, where both sides installed the AI-based MainLine product. During Rail Vision’s visit, Rail Vision led training sessions for the mining company’s team. The mining company plans on evaluating the system’s performance over the upcoming months. The mining company is one of the world’s largest producers of metals. Its operations comprise integrated...

LPL Financial Welcomes Englert Financial

Written by Customer Service on July 31, 2024. Posted in Mergers And Acquisitions.

SAN DIEGO, July 31, 2024 (GLOBE NEWSWIRE) — LPL Financial LLC (Nasdaq:LPLA) announced today that financial advisors George Englert, Kevin Englert and Carrie Hughes have joined LPL Financial’s broker-dealer, RIA and custodial platforms. They reported serving approximately $170 million in advisory, brokerage and retirement plan assets* and join LPL from Avantax, now owned by Cetera. Based in Springfield, Va., Englert Financial is a family-oriented firm founded by George Englert, an industry veteran who has worked closely with various government agencies, including the Federal Reserve Board, the Office of the Comptroller of the Currency and the Federal Deposit Insurance Corporation. His son, Kevin Englert, joined the team in 2011 after an initial career as an auditor in public accounting and the private industry. Carrie Hughes joined...

ORYZON reports financial results and corporate update for half-year ending June 30, 2024

Written by Customer Service on July 31, 2024. Posted in Earnings Releases And Operating Results.

Company granted an End-of-Phase II meeting with the FDA to discuss plans for a registrational Phase III trial with vafidemstat in Borderline Personality Disorder (BPD) Final data from PORTICO, global Phase IIb vafidemstat trial in BPD, scheduled as an oral presentation at the 37th ECNP annual conference in September Company continues to strengthen IP position in CNS with formal notices of intention to grant two patent applications in Japan covering the use of vafidemstat to treat BPD and Attention Deficit Hyperactivity disorder (ADHD) Encouraging preliminary data presented at EHA 2024 from ongoing FRIDA Phase Ib trial with iadademstat in combination with gilteritinib in relapsed/refractory FLT3-mutant AML patients; additional data planned for ASH 2024 Selected as Associated Partner in the first Important Project of Common European Interest...

Month: July 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice